Evidence map›Paper›PMID 33945026›Full record

ReviewArchives of gynecology and obstetrics2021

Immunological and physiopathological approach of COVID-19 in pregnancy.

Raquel Ferrer-Oliveras, Manel Mendoza, Sira Capote, Laia Pratcorona, Enrique Esteve-Valverde, Lluis Cabero-Roura, Jaume Alijotas-Reig

Open access · bronzeAbstract readReview
In one paragraph

Review in Archives of gynecology and obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. PostCOVID-19 Impact on Perinatal Outcomes.Diagnostics (Basel, Switzerland) · 2024
    Article
  7. Liver damage profile in COVID-19 pregnant patients.Cell communication and signaling : CCS · 2024
    Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue.International journal of environmental research and public health · 2023
    Review
  18. Article
  19. Predictors of COVID-19 severity among pregnant patients.Bosnian journal of basic medical sciences · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Raquel Ferrer-OliverasDepartment of Obstetrics and Gynaecology, Hospital Universitari Quironsalud Barcelona, Barcelona, Catalonia, Spain. raquelfo22@hotmail.com.ORCID 0000-0001-9942-7589
Manel MendozaMaternal Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.ORCID 0000-0002-3030-3833
Sira CapoteDepartment of Obstetrics and Gynaecology, Hospital Universitari Quironsalud Barcelona, Barcelona, Catalonia, Spain.
Laia PratcoronaDepartment of Obstetrics, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Enrique Esteve-ValverdeDepartment of Internal Medicine, Althaia Network Health. Manresa, Barcelona, Spain.
Lluis Cabero-RouraDepartment of Obstetrics and Gynaecology, Hospital Universitari Quironsalud Barcelona, Barcelona, Catalonia, Spain.
Jaume Alijotas-ReigSystemic Autoimmune Diseases Unit. Department of Internal Medicine-1, Vall d' Hebron University Hospital, Barcelona, Spain. jalijotas@vhebron.net.ORCID 0000-0002-9212-3619
Universitat Autònoma de Barcelona · ESHospital Quirónsalud Barcelona · ESAlthaia · ESHebron University · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease-2019 (COVID-19) related to Coronavirus-2 (SARS-CoV-2) is a worldwide health concern. Despite the majority of patients will evolve asymptomatic or mild-moderate upper respiratory tract infections, 20% will develop severe disease. Based on current pathogenetic knowledge, a severe COVID-19 form is mainly a hyperinflammatory, immune-mediated disorder, triggered by a viral infection. Due to their particular immunological features, pregnant women are supposed to be particularly susceptible to complicate by intracellular infections as well as immunological disturbances. As an example, immune-thrombosis has been identified as a common immune-mediated and pathogenic phenomenon both in COVID-19, in obstetric diseases and in COVID-19 pregnant women. According to extensive published clinical data, is rationale to expect an interference with the normal development of pregnancy in selected SARS-CoV-2-infected cases, mainly during third trimester.This manuscript provides insights of research to elucidate the potential harmful responses to SARS-CoV-2 and /or other coronavirus infections, as well as bidirectional interactions between COVID-19 and pregnancy to improve their respective management.

Indexed as

COVID-19FemaleHumansInfectious Disease Transmission, VerticalPandemicsPregnancyPregnancy Complications, InfectiousPregnant PeopleSARS-CoV-2COVID-19HyperinflammationImmune-mediatedObstetric disorderPlacental diseasePregnancy outcomeSARS-CoV-2Viral infection

Identifiers

PMID33945026
PMCPMC8093597
OpenAlexW3158096986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.